PropertyValue
nif:beginIndex
  • 0 (xsd:integer)
nif:broaderContext
nif:endIndex
  • 203 (xsd:integer)
nif:isString
  • The median survival of patients with granule cell neuronopathy is approximately 3 months without HAART therapy and up to 1.8 years in patients on HAART therapy or possibly more depending on CD4 response.
rdf:type